Second- and third-generation drug-eluting coronary stents

Strut Coverage and Vessel Wall Response to a New-Generation Paclitaxel-Eluting Stent With an Ultrathin Biodegradable Abluminal Polymer

(2010) Giulio Guagliumi et al.   Circulation-Cardiovascular Interventions

Thrombosis of Second-Generation Drug-Eluting Stents in Real Practice

(2010) José M. de la Torre Hernández et al.   JACC-Cardiovascular Interventions

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions

(2010) Martin B. Leon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Everolimus or paclitaxel stents in real life: go COMPARE

(2010) Christoph A Nienaber   LANCET

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

(2010) Elvin Kedhi et al.   LANCET

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

(2010) Klaus Rasmussen et al.   LANCET

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2010) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

(2010) Patrick W. Serruys et al.   NEW ENGLAND JOURNAL OF MEDICINE

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

(2010) Yosinobu Onuma et al.   EuroIntervention

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

(2009) Edoardo Camenzind et al.   AMERICAN HEART JOURNAL

Clinical Outcomes After Sirolimus-Eluting, Paclitaxel-Eluting, and Bare Metal Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)

(2009) Christoph A. Nienaber et al.   AMERICAN JOURNAL OF CARDIOLOGY

Safety and Efficacy of Drug-Eluting and Bare Metal Stents

(2009) Ajay J. Kirtane et al.   CIRCULATION

Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents

(2009) Jeffrey J. Popma et al.   Circulation-Cardiovascular Interventions

Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial

(2009) B. E. Claessen et al.   Circulation-Cardiovascular Interventions

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

(2009) P. Barlis et al.   EUROPEAN HEART JOURNAL

Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice

(2009) Chaim Lotan et al.   JACC-Cardiovascular Interventions

3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions

(2009) Scot Garg et al.   JACC-Cardiovascular Interventions

Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions

(2008) Johannes Ruef et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

(2008) Gregg W. Stone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents

(2008) Pallav Garg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents

(2008) Masaki Awata et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice

(2008) Peter Wenaweser et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

(2008) John A Ormiston et al.   LANCET